Biotechnology Bulletin ›› 2016, Vol. 32 ›› Issue (6): 219-225.doi: 10.13560/j.cnki.biotech.bull.1985.2016.06.032

• Research report • Previous Articles     Next Articles

Renaturation Technology of Recombinant Fusion Protein Trx-IFN-CSP

HUANG Yan-ting1,2,3, LU Xue-mei2,3, YANG Xiao-rong1, JIN Xiao-bao2,3, ZHU Jia-yong2,3   

  1. 1. The First Affiliated Hospital of Guangdong Pharmaceutical University,Guangzhou 510006
    2. Institution of Pharmaceutical Bioactive Substances,School of Basic Courses,Guangdong Pharmaceutical University,Guangzhou 510006
    3.Guangdong Key Laboratory of Pharmaceutical Bioactive Substances,Guangzhou 510006
  • Received:2015-08-02 Online:2016-06-27 Published:2016-06-28

Abstract: This work is to establish and optimize the method of refolding fusion protein Trx-IFN-CSP. The refolding of recombinant protein in vitro was studied,i.e.,investigating the effects of pH,temperature,protein concentration,redox systems and auxiliary refolding molecules on the refolding process of fusion protein. The results were as below. The proper measure to refold the Trx-IFN-CSP was to obtain the inclusion bodies by repeated combined freeze-thaw with ultrasonic to crack bacteria. The inclusion bodies were preliminarily purified using scrub solution of 1% TritonX-100,2 mol/L urea,and 2% DOC,and then denatured in 6 mol/L guanidine hydrochloride. After the pulse dilution,the renaturation was conducted under 4℃ by gradient dialysis with the assistance of L-Arg. After the Trx-tag was removed by recombinant enterokinase digestion,approximately 110-130 mg of the pure recombinant liver-targeted interferon was obtained from 1 L Escherichia coli culture. Each batch of protein had a purity of over 95% and antibacterial activities were about 1.9-2.4×108 U/mg,thus the technology of preparation was stable.

Key words: fusion protein, liver-targeted interferon, inclusion body, pulse dilution, gradient dialysis